Brigitte Sturm

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

Eppie M. Yiu, Geneieve Tai, Roger E. Peverill et al. · Journal of Neurology · 2015 · 110 citations

Open-label Trial, Pharmacology, Clinical Trials +5

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

Sylvia Boesch, Brigitte Sturm, Sascha Hering et al. · Annals of Neurology · 2007 · 108 citations

Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl

Hilde Laggner, Markus K. Muellner, Sabine M. Schreier et al. · Free Radical Research · 2007 · 104 citations

Oxysterol, Biochemistry, Hocl Modification +12

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Esther Jacobs, Jan C.M. Hendriks, Berry L.J.H. van Tits et al. · Analytical Biochemistry · 2005 · 102 citations

Medicine, Transfusion Medicine, Chronic Kidney Disease +9

Recombinant human erythropoietin: effects on frataxin expression <i>in vitro</i>

Brigitte Sturm, Daniela Stupphann, Christoph Kaun et al. · European Journal of Clinical Investigation · 2005 · 100 citations · Full text